These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16809706)

  • 21. Investigating pharmaceutical marketing in Canada using American prosecutions.
    Shoucri R; Persaud N
    Int J Risk Saf Med; 2014; 26(3):147-53. PubMed ID: 25214160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keeping the door open to pharma.
    Harris J
    Fam Pract Manag; 2009; 16(4):10. PubMed ID: 19630169
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug companies monitor prescriptions and sales to fine-tune their marketing strategies.
    Prescrire Int; 2010 Jun; 19(107):140-1. PubMed ID: 20738051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key opinion leaders: used as a marketing tool by drug companies.
    Prescrire Int; 2012 Jun; 21(128):163-5. PubMed ID: 22822596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical marketing in a new age. Effective campaigns still need to focus on what customers want.
    Rao SK
    Mark Health Serv; 2002; 22(1):6-12. PubMed ID: 11881547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. European drug agency's attempts to improve transparency stalled by legal action from two US drug companies.
    Dyer C
    BMJ; 2013 Jun; 346():f3588. PubMed ID: 23733481
    [No Abstract]   [Full Text] [Related]  

  • 28. How to combat Pharma's costly coupon programs.
    Cahn L
    Manag Care; 2012 May; 21(5):22-6. PubMed ID: 22670483
    [No Abstract]   [Full Text] [Related]  

  • 29. 'Get with the Program!': pharmaceutical marketing, symptom checklists and self-diagnosis.
    Ebeling M
    Soc Sci Med; 2011 Sep; 73(6):825-32. PubMed ID: 21835526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation.
    Zalesky CD
    J Health Law; 2006; 39(2):235-64. PubMed ID: 17002233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug companies and clinical psychology.
    Baker E; Newnes C; Myatt H
    Ethical Hum Sci Serv; 2003; 5(3):247-53. PubMed ID: 15139338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spin your science into gold: direct to consumer marketing within social media platforms.
    Egilman D; Druar NM
    Work; 2012; 41 Suppl 1():4494-502. PubMed ID: 22317414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical industry guide. The chosen few.
    Watts G
    Health Serv J; 2002 Nov; 112(5833):suppl 10-1. PubMed ID: 12478711
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical industry guide. It all ads up.
    Moore A
    Health Serv J; 2002 Nov; 112(5833):suppl 17. PubMed ID: 12478713
    [No Abstract]   [Full Text] [Related]  

  • 35. Applying social marketing in health care: communicating evidence to change consumer behavior.
    Evans WD; McCormack L
    Med Decis Making; 2008; 28(5):781-92. PubMed ID: 18556638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New marketing code for Indian drug companies favours the companies, critics say.
    Chaudhuri M
    BMJ; 2012 Nov; 345():e7495. PubMed ID: 23138035
    [No Abstract]   [Full Text] [Related]  

  • 37. Chinese tobacco companies' social media marketing strategies.
    Wang F; Zheng P; Freeman B; Chapman S
    Tob Control; 2015 Jul; 24(4):408-9. PubMed ID: 24898124
    [No Abstract]   [Full Text] [Related]  

  • 38. Marketing versus evidence-based medicine.
    Braillon A; Bewley S; Herxheimer A; Mansfield P; Lexchin J; Menkes DB; Ziganshina LE; Montastruc JL
    Lancet; 2012 Jul; 380(9839):340. PubMed ID: 22841337
    [No Abstract]   [Full Text] [Related]  

  • 39. US drug companies paid $15bn in fines for fraudulent marketing in past five years.
    Tanne JH
    BMJ; 2010 Dec; 341():c7360. PubMed ID: 21177361
    [No Abstract]   [Full Text] [Related]  

  • 40. Retailer participation in cigarette company incentive programs is related to increased levels of cigarette advertising and cheaper cigarette prices in stores.
    Feighery EC; Ribisl KM; Schleicher NC; Clark PI
    Prev Med; 2004 Jun; 38(6):876-84. PubMed ID: 15193911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.